Skip to content 
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. more
| Time Frame | LFMDP | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 0.97% | -3.37% | -1.83% |
| 1-Month Return | 1.1% | -7.71% | -5.69% |
| 3-Month Return | 7.73% | -6.8% | -5.05% |
| 6-Month Return | -4.03% | 5.93% | -2.74% |
| 1-Year Return | -6.88% | -1.55% | 14.96% |
| 3-Year Return | 60.28% | 14% | 64.66% |
| 5-Year Return | -4.96% | 25.13% | 65.14% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 92.88M | 119.03M | 152.55M | 212.45M | 194.06M | [{"date":"2021-12-31","value":43.72,"profit":true},{"date":"2022-12-31","value":56.03,"profit":true},{"date":"2023-12-31","value":71.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":91.34,"profit":true}] |
| Cost of Revenue | 18.00M | 18.67M | 18.90M | 24.07M | 39.29M | [{"date":"2021-12-31","value":45.8,"profit":true},{"date":"2022-12-31","value":47.51,"profit":true},{"date":"2023-12-31","value":48.1,"profit":true},{"date":"2024-12-31","value":61.25,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 74.88M | 100.37M | 133.65M | 188.39M | 154.76M | [{"date":"2021-12-31","value":39.75,"profit":true},{"date":"2022-12-31","value":53.28,"profit":true},{"date":"2023-12-31","value":70.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":82.15,"profit":true}] |
| Gross Margin | 80.62% | 84.32% | 87.61% | 88.67% | 79.75% | [{"date":"2021-12-31","value":90.92,"profit":true},{"date":"2022-12-31","value":95.09,"profit":true},{"date":"2023-12-31","value":98.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":89.94,"profit":true}] |
| Operating Expenses | 129.18M | 143.81M | 148.14M | 204.53M | 144.01M | [{"date":"2021-12-31","value":63.16,"profit":true},{"date":"2022-12-31","value":70.31,"profit":true},{"date":"2023-12-31","value":72.43,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":70.41,"profit":true}] |
| Operating Income | (54.30M) | (43.45M) | (14.49M) | (16.14M) | (7.67M) | [{"date":"2021-12-31","value":-5430108100,"profit":false},{"date":"2022-12-31","value":-4344778100,"profit":false},{"date":"2023-12-31","value":-1448927300,"profit":false},{"date":"2024-12-31","value":-1614468100,"profit":false},{"date":"2025-12-31","value":-766969400,"profit":false}] |
| Total Non-Operating Income/Expense | (10.03M) | (2.49M) | (5.74M) | (4.36M) | - | [{"date":"2021-12-31","value":-1003499100,"profit":false},{"date":"2022-12-31","value":-248849200,"profit":false},{"date":"2023-12-31","value":-573922600,"profit":false},{"date":"2024-12-31","value":-436363400,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | (61.32M) | (44.66M) | (17.41M) | (18.33M) | (10.19M) | [{"date":"2021-12-31","value":-6131635600,"profit":false},{"date":"2022-12-31","value":-4466032700,"profit":false},{"date":"2023-12-31","value":-1741105700,"profit":false},{"date":"2024-12-31","value":-1832649800,"profit":false},{"date":"2025-12-31","value":-1018651200,"profit":false}] |
| Income Taxes | 7.70K | 360.70K | 428.00K | 402.00K | 45.72K | [{"date":"2021-12-31","value":1.8,"profit":true},{"date":"2022-12-31","value":84.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.93,"profit":true},{"date":"2025-12-31","value":10.68,"profit":true}] |
| Income After Taxes | (61.32M) | (45.02M) | (17.84M) | (18.73M) | - | [{"date":"2021-12-31","value":-6132405600,"profit":false},{"date":"2022-12-31","value":-4502102700,"profit":false},{"date":"2023-12-31","value":-1783905700,"profit":false},{"date":"2024-12-31","value":-1872849800,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | (61.32M) | (45.02M) | (26.19M) | (18.73M) | - | [{"date":"2021-12-31","value":-6132405600,"profit":false},{"date":"2022-12-31","value":-4502102700,"profit":false},{"date":"2023-12-31","value":-2619201800,"profit":false},{"date":"2024-12-31","value":-1872849800,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | (60.90M) | (45.54M) | (20.60M) | (18.88M) | 14.35M | [{"date":"2021-12-31","value":-424.25,"profit":false},{"date":"2022-12-31","value":-317.23,"profit":false},{"date":"2023-12-31","value":-143.49,"profit":false},{"date":"2024-12-31","value":-131.54,"profit":false},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | - | - | - | (1.20) | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-120.02,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| LFMDP | |
|---|---|
| Cash Ratio | 0.88 |
| Current Ratio | 1.25 |
| Quick Ratio | 1.18 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| LFMDP | |
|---|---|
| ROA (LTM) | -6.54% |
| ROE (LTM) | -131.16% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| LFMDP | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.67 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.33 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| LFMDP | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
LifeMD Inc Preferred Series A (LFMDP) share price today is $23.165
Yes, Indians can buy shares of LifeMD Inc Preferred Series A (LFMDP) on Vested. To buy
Yes, you can purchase fractional shares of LifeMD Inc Preferred Series A (LFMDP) via the Vested app. You can start investing in LifeMD Inc Preferred Series A (LFMDP) with a minimum investment of $1.
You can invest in shares of LifeMD Inc Preferred Series A (LFMDP) via Vested in three simple steps:
The 52-week high price of LifeMD Inc Preferred Series A (LFMDP) is $24.59. The 52-week low price of LifeMD Inc Preferred Series A (LFMDP) is $18.06.
The price-to-earnings (P/E) ratio of LifeMD Inc Preferred Series A (LFMDP) is
The price-to-book (P/B) ratio of LifeMD Inc Preferred Series A (LFMDP) is 0.00
The dividend yield of LifeMD Inc Preferred Series A (LFMDP) is 0.00%
The market capitalization of LifeMD Inc Preferred Series A (LFMDP) is
The stock symbol (or ticker) of LifeMD Inc Preferred Series A is LFMDP
Consider the share price of LifeMD Inc Preferred Series A as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether LifeMD Inc Preferred Series A has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in LifeMD Inc Preferred Series A shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the LifeMD Inc Preferred Series A stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of LifeMD Inc Preferred Series A and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that LifeMD Inc Preferred Series A stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
